Skip to main content
H.R. 9661 119th Congress House

Expedited Access to Biosimilars Act

Official title: To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical stud… Show full official titleShow less

Official title: To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.

Introduced: July 14, 2026 Introduced by: Nicholas A. Langworthy Republican · New York See on congress.gov
Health
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 14, 2026
Referred to the House Committee on Energy and Commerce.
Jul 14, 2026
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now July 14, 2026

Referred to the House Committee on Energy and Commerce.

 Hearings & markups 1
 Related & companion bills 1
  • S 5059 A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 13

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 13 filings →
 Cosponsors 2
All 2 Democratic 1 Republican 1
R
Wittman, Robert J.
Virginia · Jul 21, 2026
 D
Schrier, Kim
Washington · Jul 14, 2026
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 9661: Expedited Access to Biosimilars Act. 119th Congress. Open America. https://openamerica.io/bill/119-HR-9661/
MLA
"H.R. 9661: Expedited Access to Biosimilars Act." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-9661/.
Bluebook (legal)
H.R. 9661, 119th Cong. (2026), https://openamerica.io/bill/119-HR-9661/.
Markdown link
[H.R. 9661: Expedited Access to Biosimilars Act](https://openamerica.io/bill/119-HR-9661/)
Report a problem